Drugs

Acknowledgement to Referees

The Biology and Clinical Development of MEK Inhibitors for Cancer

Jason J. Luke, Patrick A. Ott, Geoffrey I. Shapiro

Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis

Yoshiya Tanaka, Shintaro Hirata

Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical Considerations

Nicholas W. Carris, James R. Taylor, John G. Gums

Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes

Lesley J. Scott

Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus

Lesley J. Scott

Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease

James E. Frampton

Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes

Greg L. Plosker

Ripasudil: First Global Approval

Karly P. Garnock-Jones

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity

Mohamad Mohty, Andrea Bacigalupo, Faouzi Saliba, Andreas Zuckermann, Emmanuel Morelon, Yvon Lebranchu